Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

[Halothane hepatitis]

J Fehér1, B Vásárhelyi, A Blázovics

  • 1Semmelweis Orvostudományi Egyetem, II. sz. Belgyógyászati Klinika, Budapest.

Orvosi Hetilap
|August 15, 1993
PubMed
Summary

Halothane anesthesia can cause liver damage, with mild enzyme elevation in one-fifth of patients. Fatal halothane hepatitis is rare but linked to risk factors like genetics and repeated exposure, emphasizing prevention.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Eye on the Gut: Irritable Eye Syndrome

La Clinica terapeutica·2019
Same author

Characterization of the thrombin generation profile in systemic lupus erythematosus.

Physiology international·2017
Same author

Occlusion of retinal capillaries caused by glial cell proliferation in chronic ocular inflammation.

Folia morphologica·2015
Same author

The Use of the S-MART Tourniquet in Hand Surgery: A Safe and Effective Way to Provide a Bloodless Field.

Surgery research and practice·2014
Same author

Soluble urokinase plasminogen activator receptor, the candidate prophetic biomarker in severe inflammatory response syndrome.

Journal of internal medicine·2014
Same author

Protective effect of CV247 against cisplatin nephrotoxicity in rats.

Human & experimental toxicology·2013

Area of Science:

  • Anesthesiology
  • Hepatology
  • Toxicology

Background:

  • Halothane is a widely used anesthetic.
  • Halothane anesthesia is associated with liver damage.
  • The incidence of fatal halothane hepatitis is rare.

Purpose of the Study:

  • To review recent research on halothane hepatotoxicity.
  • To identify risk factors for halothane-induced liver injury.
  • To discuss strategies for preventing halothane hepatotoxicity.

Main Methods:

  • Literature review of studies on halothane hepatotoxicity.
  • Analysis of risk factors associated with halothane liver injury.
  • Summary of current understanding of halothane metabolism and immune response in liver toxicity.

Main Results:

  • Mild liver enzyme elevation occurs in approximately 20% of patients post-halothane anesthesia.
  • Risk factors for severe halothane hepatitis include genetic predisposition, repeated exposure, female sex, obesity, and enzyme induction.
  • Halothane metabolism and immune system function are critical in its liver toxicity.

Conclusions:

  • Halothane-induced liver damage is a significant concern in anesthesiology.
  • Understanding risk factors is crucial for managing halothane hepatotoxicity.
  • Effective prevention strategies for halothane hepatotoxicity should be explored and implemented.

Related Experiment Videos